FIELD: biotechnology.
SUBSTANCE: isolated recombinant adenosine deaminase is described, which comprises polypeptide SEQ ID NO: 1 or a version polypeptide SEQ ID NO: 1 of isolated recombinant adenosine deaminase, where the version polypeptide SEQ ID NO: 1 comprises one or more amino acid substitutions selected from the group consisting of: Gin instead Lysl98; Ala instead Thr245; and Arg instead of Gly351, and DNA encoding it. The conjugate of polyalkylene oxide with the said adenosine deaminase for treatment of adenosine deaminase-mediated diseases is presented where adenosine deaminase comprises from 11 to 17 chains of polyalkylene oxide with a molecular weight of 5 kDa for ADA protein. The methods of purification of the recombinant adenosine deaminase are proposed, including protein purification using ion exchange chromatography, or protein purification using hydrophobic interaction chromatography. Also the preparations of recombinant adenosine deaminase produced by these methods are provided.
EFFECT: invention enables to obtain recombinant adenosine deaminase, having increased stability.
14 cl, 1 tbl, 10 ex
| Title |
Year |
Author |
Number |
| ENZYMATIC ANTICANCER THERAPY |
2008 |
- Filpula Dehvid R.
- Sapra Pudzha
|
RU2481855C2 |
| PLASMID FOR EXPRESSION IN CELLS OF BACTERIUM BELONGING TO Escherichia CLASS, NON-ACTIVE PREDECESSOR OF DNase I OF HUMAN OR ITS MUTEINS; BACTERIUM BELONGING TO Escherichia CLASS, - PRODUCER OF NON-ACTIVE PREDECESSOR OF RECOMBINANT DNase I OF HUMAN OR ITS MUTEIN; PREDECESSOR OF RECOMBINANT DNase I OF HUMAN OR ITS MUTEIN; METHOD FOR OBTAINING RECOMBINANT DNase I OF HUMAN OR ITS MUTEIN; METHOD FOR OBTAINING CONJUGATES OF POLYETHYLENE GLYCOL AND RECOMBINANT MUTEIN OF HUMAN DNase I, FERMENTATIVE ACTIVE CONJUGATE OF MUTEIN OF RECOMBINANT DNase I OF HUMAN |
2011 |
- Orlova Nadezhda Aleksandrovna
- Vorob'Ev Ivan Ivanovich
|
RU2502803C2 |
| COMPOSITIONS AND METHODS OF USING FOR TREATING METABOLIC DISORDERS |
2014 |
- Metern Khyugo
- Lindkhout Derrin Entoni
- Khaldankar Radzh
- Khorner Dzheffri
|
RU2704285C2 |
| URATE OXIDASE CONJUGATES, PHARMACEUTICAL COMPOSITION FOR REDUCTION IN URIC ACID LEVELS AND METHOD FOR PREPARING CONJUGATES STATED ABOVE |
2008 |
- Villiamz L. Dehvid
- Khershfild Majkl S.
- Kelli S'Juzehn Dzh.
- Sajfer Mark Dzh. P.
- Shermen Meri R.
|
RU2443426C2 |
| ALDEHYDE MARKED IMMUNOGLOBULIN POLYPEPTIDES AND METHODS OF THEIR APPLICATION |
2012 |
- Barfild Robin M.
- Brejdenbakh Mark Alan
- Dekhart Gregori U.
- Rabuka Devid
|
RU2606016C2 |
| MUTEINS OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR GLYPICAN-3 (GPC3) |
2016 |
- Huelsmeyer, Martin
- Matschiner, Gabriele
- Wiedenmann, Alexander
- Aloe, Michaela
- Bel Aiba, Rachida Siham
- Allersdorfer, Andrea
- Hinner, Marlon
|
RU2756318C2 |
| MUTEINS OF TEAR LIPOCALIN, POSSESSING AFFINITY TO HUMAN C-MET RECEPTOR TYROSINE KINASE AND METHODS OF OBTAINING THEM |
2009 |
- Matshiner Gabriehle
- Khol'Baum Andreas
- Khuehl'Smejer Martin
- Trentmann Stefan
|
RU2515063C9 |
| PROTEINS SPECIFIC FOR CD137 |
2016 |
- Bel Aiba, Rachida Siham
- Allersdorfer, Andrea
- Olwill, Shane
- Rothe, Christine
- Hinner, Marlon
|
RU2736312C2 |
| MODIFIED ANTAGONIST OF RECEPTOR IL-4 AND PURIFIED POLYNUCLEOTIDE INTENDED FOR ITS PRODUCTION |
2004 |
- Pehn Klark
- Rokznjak Stiv
- Griv Dzheffri Majkl
- Jung Stefani L.
- Longfre Malinda
- Vong Teresa Mo-Fan
- Tomkinson Ehdrian
|
RU2389796C2 |
| PURIFIED PREPARATION OF URATE OXIDASE, PURIFIED RECOMBINANT URATE OXIDASE, CONJUGATE (VERSIONS) AND PHARMACEUTICAL COMPOSITION FOR REDUCING MAMMALIAN LIQUID OR TISSUE URIC ACID, PURIFIED FRAGMENTS OF URATE OXIDASE AND METHOD FOR URATE OXIDASE PURIFICATION |
2009 |
- Villiamz, L., Dehvid
- Kelli, S'Juzehn, Dzh.
- Sajfer, Mark, Dzh., P.
- Khershfild, Majkl, S.
- Shermen, Meri, R.
|
RU2557318C9 |
